480 results on '"Gardner, Jerry"'
Search Results
2. Chief Judge Abby Abinanti, Yurok Tribe
3. Biobehavioral effects of Tai Chi Qigong in men with prostate cancer: Study design of a three-arm randomized clinical trial.
4. Post-reflux swallow-induced peristaltic wave (PSPW): physiology, triggering factors and role in reflux clearance in healthy subjects
5. Biobehavioral effects of Tai Chi Qigong in men with prostate cancer: Study design of a three-arm randomized clinical trial
6. IDENTIFYING DIFFERENT PHENOTYPES OF SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE USING ARTIFICIAL INTELLIGENCE
7. GASTRIC ACIDITY IN DIFFERENT PHENOTYPES OF SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE
8. Timing and Outcomes of Endoscopy for esophageal Food Bolus Impaction
9. Oscillating Esophageal Acid Sensitivity in Symptomatic Reflux Hypersensitivity and Functional Heartburn
10. PROFILE : JUDGE STACY LEEDS
11. MY STORY: CONVOYING ROUTE 66 A personal travelog
12. The relationship between esophageal acidity and symptom frequency in symptomatic nonerosive gastroesophageal reflux disease
13. Findings from a National Needs Assessment of American Indian/Alaska Native Child Welfare Programs
14. Timing and Outcomes of Endoscopy for Esophageal Food Bolus Impaction
15. Levels of fatigue and distress in senior prostate cancer survivors enrolled in a 12-week randomized controlled trial of Qigong
16. Relationship between Process and Outcome in Ambulatory Care
17. Modulation of Cholecystokinin Activity by Albumin
18. Direct Demonstration of Three Different States of the Pancreatic Cholecystokinin Receptor
19. Idea Bank
20. Su370 USING CLINICAL TRIAL RESULTS TO REMOVE THE UNCERTAINTY IN TREATING AN INDIVIDUAL PATIENT WITH CIRRHOSIS AND THROMBOCYTOPENIA
21. Missed Opportunity in Zollinger–Ellison Syndrome Research
22. Control of Nocturnal Gastric Acidity: A Role for Low Dose Bedtime Ranitidine to Supplement Daily Omeprazole
23. Su1657 IN AN INDIVIDUAL WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID, THE PROBABILITY OF PRURITUS IS HIGHER THAN THAT OF A CLINICAL RESPONSE, BUT PRURITUS IS LESS LIKELY TO BE ATTRIBUTABLE TO THE DRUG.
24. GERD Increased gastric acid secretion as a possible cause of GERD
25. Diagnostic Performance of Esophageal pH Electrodes at Different Locations
26. Clinicians and FDA Decisions
27. Prospective study of efficacy and safety of lansoprazole in Zollinger-Ellison syndrome
28. Peptic ulcer perforation as the presentation of Zollinger-Ellison syndrome
29. Receptor antagonists for gastrointestinal peptides
30. Gastric acid suppression by rabeprazole: how much is enough to normalize esophageal acid exposure in gastroesophageal reflux disease?: 59E.
31. Book Reviews
32. [35] Receptor identification
33. Role of Receptors in Expression of Gastrointestinal Hormone Function
34. [18] Dispersed pancreatic acinar cells and pancreatic acini
35. Cholecystokinin Receptor Antagonists: Ability to Distinguish Various Classes of Cholecystokinin Receptors
36. Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors
37. The Internet and the Journal
38. Structure-Function Studies of Agonists and Antagonists for Gastrointestinal Peptide Receptors on Pancreatic Acinar Cells
39. Specific Binding and Ability of Vasoactive Intestinal Octacosa-Peptide (VIP) to Activate Adenylate Cyclase in Isolated Pancreatic Acinar Cells from the Guinea Pig
40. Attributable Benefit -- Interpreting Results from Clinical Trials of Newer Treatments for Constipation at the Level of the Individual Patient
41. Levels of fatigue and distress in senior prostate cancer survivors enrolled in a 12-week randomized controlled trial of Qigong
42. Persistent constipation and abdominal adverse events with newer treatments for constipation
43. Tu1105 Attributable Risk - Interpreting Side Effects in Clinical Trials of Newer Treatments for Constipation at the Level of the Individual Patient
44. Effects of cations on ouabain binding by intact human erythrocytes
45. Plasma VIP in patients with watery diarrhea syndrome
46. Biochemical basis of action of gastrointestinal hormones
47. Current Management of Zollinger-Ellison Syndrome
48. Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors
49. 1018 A Questionable Investment for Our Patients: Challenging the Efficacy of New Therapies for Opioid-Induced and Chronic Idiopathic Constipation
50. Su1544 - Attributable Benefit -- Interpreting Results from Clinical Trials of Newer Treatments for Constipation at the Level of the Individual Patient
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.